RayzeBio Inc. Common Stoc...

NASDAQ: RYZB · Real-Time Price · USD
62.49
0.01 (0.02%)
At close: Feb 23, 2024, 10:00 PM

RayzeBio Common Stock Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q3 2023 Q4 2022 Q3 2022
Period Ending Sep 30, 2023 Dec 31, 2022 Sep 30, 2022
Net Income
-53.34M -35.15M -20.45M
Depreciation & Amortization
1.32M 823K 404K
Stock-Based Compensation
6.12M 3.55M 1.45M
Other Working Capital
1.97M 1.9M -296K
Other Non-Cash Items
6.78M 6.72M 6.64M
Deferred Income Tax
-3.14M -867K 23K
Change in Working Capital
1.97M 1.9M -296K
Operating Cash Flow
-40.28M -23.02M -12.23M
Capital Expenditures
-18.93M -5.41M -2.6M
Cash Acquisitions
n/a n/a n/a
Purchase of Investments
-246.75M -129.74M -32.85M
Sales Maturities Of Investments
121.36M 66.36M 41.96M
Other Investing Acitivies
n/a n/a n/a
Investing Cash Flow
-144.32M -68.78M 6.5M
Debt Repayment
n/a n/a n/a
Common Stock Repurchased
-43K -43K -12K
Dividend Paid
n/a n/a n/a
Other Financial Acitivies
470.88M 159.33M 159.68M
Financial Cash Flow
470.88M 159.33M 159.68M
Net Cash Flow
286.28M 67.53M 153.95M
Free Cash Flow
-59.22M -28.43M -14.83M